View drug registration information details.
Items | Registration information |
ID | 481 |
No | 481 |
Brand Name | CYPRESS |
Ingredients | CYPROTERONE ACETATE PH.EUR 2 MG, ETHINYLESTRADIOL PH.EUR 0.035 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | ALU/PVDC |
Storage | STORE BELOW 30C |
Shelf Life | 2 YEARS |
Pack Size | A BLISTERPACK OF 21 TABLETS |
Dispensing Category | PRESCRIPTION |
ATC Classification | G03HB01 |
Pharmaceutical Class | ANTIANDROGEN |
Indications | TREATMENT OF MODERATE TO SEVERE ACNE RELATED TO ANDROGEN-SENSITIVITY (WITH OR WITHOUT SEBORRHOEA) AND/OR HIRSUTISM, IN WOMEN OF REPRODUCTIVE AGE. FOR THE TREATMENT OF ACNE, CYPRESS SHOULD ONLY BE USED AFTER THERAPY OR SYSTEMIC ANTIBIOTIC TREATMENTS HAVE FAILED |
Contraindications | |
Side Effects | NAUSEA, ABDOMINAL PAIN, WEIGHT INCREASED, HEADACHE, DEPRESSED MOOD, MOOD ALTERED, BREAST PAIN, BREAST TENDERNESS |
Unit Price | |
EDL |
No |
Description | ROUND, LIGHT PINK, BICONVEX, FILM COATED TABLET DEBOSED " T" ON ONE SIDE AND OTHER SIDE PLAIN |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | MYLAN LABORATORIES LIMITED |
Country | INDIA |
Import Registration No | G/28/1297 |
Import Registration Date | 2016-11-04 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-07-14 |
FDD Registration No | 01 I 5665/24 |
FDD Registration Date | 2024-01-26 |
Expiry Date | 2027-01-25 |
Back to drug list
|